Found: 6
Select item for more details and to access through your institution.
APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 529, p. 1, doi. 10.1126/scitranslmed.aay1809
- By:
- Publication type:
- Article
Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology.
- Published in:
- Molecular Neurodegeneration, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13024-023-00599-3
- By:
- Publication type:
- Article
APOE2 Exacerbates TDP‐43 Related Toxicity in the Absence of Alzheimer Pathology.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 4, p. 830, doi. 10.1002/ana.26580
- By:
- Publication type:
- Article
LRP1 is a neuronal receptor for α-synuclein uptake and spread.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-022-00560-w
- By:
- Publication type:
- Article
TDP-43 Pathology in Alzheimer's Disease.
- Published in:
- Molecular Neurodegeneration, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13024-021-00503-x
- By:
- Publication type:
- Article